Fundraising Fox

Medical Devices Series C Investors & VC Firms

439 firms in this list, with a median first check of $1M. 93 of them lead rounds. Generated from verified public data and updated continuously.

Breyer Capital
AustinPre-Seed–Growth$500K – $10M
9 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
45 people
US Venture Partners
Menlo ParkSeed–Late Stage$500K – $10M
9 people
Olive Tree Capital
BostonSeed–Late Stage
5 people
Delta-v Capital
DenverSeries C–Growth$2M – $10M
34 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
Aisling Capital
New YorkSeed–Series C
18 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Pitango
Tel AvivPre-Seed–Late Stage$4M – $100M
40 people
Casdin Capital
New YorkSeed–Series C
39 people
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
27 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
31 people
LRVHealth
BostonSeed–Late Stage$500K – $1M
31 people
Kfund
MadridPre-Seed–Growth$108K – $10.8M
25 people
Norrsken VC
StockholmSeed–Growth$1.1M – $3.2M
25 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
16 people
LB Investment
SeoulSeries A–Late Stage
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
Medicxi
LondonPre-Seed–Late Stage
39 people
Johnson & Johnson Innovation – JJDC
New BrunswickSeed–Growth
41 people
OSAKA University Venture Capital
OsakaPre-Seed–Growth$3M – $142M
20 people
Agent Capital
WalthamPre-Seed–Late Stage
26 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.